LVCLF 0.01 Living Cell Technologies Limited
| Range: | 4.0E-4-0.0127 | Vol Avg: | 3540 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0.73 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Jun 01 2010 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | AU0000296022 | Country: | AU | ||
| CEO: | Mr. David Richard Hainsworth | Website: | https://www.lctglobal.com | ||||
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow